Modern diagnostic systems help cure

Maintaining one’s health is the most important thing in life for most people. The chances of growing old in good health are better today than ever before. Modern medicine and its diagnostic methods make it possible. Ingenious methods allow diseases to be detected before they can cause irreversible damage.

Modern laboratory diagnostic tests play a crucial role in the treatment of a disease. They help confirm or dispel the suspicion of a disease. Patient specimens such as body fluids, stool or tissue samples are tested in the medical laboratory. What began earlier with simple analyses has in the meantime developed into a high-tech field of medicine. Diagnostic laboratory tests show whether you are healthy or whether there are changes which may lead to a disease. These help identify disorders within the body before they affect your life, or verify disease pathogens and thus offer the possibility for targeted therapy. Thus, through laboratory testing, the attending physician obtains vital information for the diagnosis of a disease, on the course of a disease and the therapeutic outcome.

For more than 10 years, the company Hain Lifescience has manufactured diagnostic test systems. With these tests definite statements can be made, for example about the presence of hereditary diseases. If such a predisposition is known a patient might adjust his/her lifestyle to it to prevent the onset of the disease or to have a positive effect on the course of the disease.
Other test systems are used to identify bacteria which cause diseases such as tuberculosis or hospital infections. These are widespread, and early diagnosis along with targeted therapy also helps in this case to prevent a severe course of the disease. Based on our DNA•STRIP^® and GenoQuick^® technology platforms, the detection systems for mycobacteria and methicillin-resistant Staphylococcus aureus (MRSA) offer a solution for central community health problems and are therefore in the focus of international interest. The GenoQuick^® MRSA test system offers the optimal basis for admission screening in hospitals and thus for reducing the increasing prevalence of MRSA. The GenoType^® MTBDRplus is favoured as a highly specific and simultaneously practical solution for the identification of resistant mycobacteria in the fight against increasing numbers of tuberculosis cases in the third world. In this regard, Hain Lifescience is cooperating with international institutions affiliated with the WHO.

Also periodontosis (commonly referred to as “gum disease”) is caused by bacteria. A simple and painless analysis using the micro-IDent^®test system reliably determines the presence and concentration of the hazardous bacteria. Through treatment based on the result the impending loss of teeth can be prevented in most cases. This test is used by most dental practices in Germany and is also the most frequently used test system worldwide for this examination.

The constantly strong corporate growth of Hain Lifescience is in particular due to substantial capital investment in in-house research and development and the innovative products of the highest quality that result from this. Close cooperation with leading national and international universities and reference centres, clinics and medical specialists in practice guarantee timely transfer of the newest scientific knowledge into products for routine use. Since we attach great value on the inspected quality of our products during development, production and marketing, comprehensive quality control as well as the certified quality management according to ISO9001/13485 and the fulfillment of the European in-vitro diagnostics guidelines are naturally a standard for us. This allows us to always keep our product portfolio in line with the most current state of knowledge and developments, and thereby to serve the interest of our customers and to constantly improve our customer service.

Thus, diagnostic testing plays an important role in terms of prevention and early detection of diseases. Only if the physician knows the patient’s individual needs the treatment can be customized to the patient’s special situation. Thereby any complications can be detected early on and long-term damage to one’s health can be prevented.

The company Hain Lifescience

Hain Lifescience GmbH, founded in 1988, is the manufacturer and distributor of such molecular biology diagnosis systems for the laboratory. The cornerstone of the company was laid in 1986 with the establishment of a business partnership by brothers David and Tobias Hain. While it originally started purely as a mail-order company, the focus of the company today is particularly on the independent development, production and distribution of modern diagnostic systems in over 50 countries. The ever-increasing number of employees and the new construction of a three-storey office and laboratory facility , completed in 2007, reflect the importance of these test systems in modern medicine. Based on the continuous expansion of the company’s facilities, Hain Lifescience currently has more than 70 employees in Nehren in the district of Tübingen. Additional expansion steps include the establishment of subsidiaries, for example in Spain and East Africa.